Abstract
Type 2 diabetes (T2D) and chronic kidney disease (CKD) are closely linked. This study aimed to describe and analyze the relations between renal function and glycemic control in T2D patients with overt nephropathy. Data were collected from a French observational prospective multicenter study. Patients included were adults with T2D, clinical proteinuria and an estimated glomerular filtration rate (eGFR) over 15 mL/min/1.73 m(2). Baseline data and glycemic control after a one-year follow-up are presented here. Data from 986 adult patients were analyzed. Mean age was 70 years. Mean eGFR was 42 mL/min/1.73 m(2), 66% of patients had proteinuria above 1g/day. HbA1c was higher in patients with lower eGFR in a model adjusted to age, gender, body mass index, hemoglobin level and erythropoietin use. Statistical significance was lost when stepwise multivariate analysis took into account the type of pharmacological treatment used to treat hyperglycemia.The type of antidiabetic agents differed across eGFR strata. Below 60 mL/min/1.73 m(2), the use of metformin declined while the use of insulin increased.After one year of follow up, 35% of patients had persistently poor or worsened glycemic control (HbA1c>8%). The only covariate independently...Continue Reading
References
Nov 1, 1995·Journal of Clinical Pharmacology·N C SambolM G Cogan
Dec 16, 1998·Diabetes Care·R C Turner
May 20, 1999·Diabetes Care·J V SelbyJ B Brown
Jun 29, 2004·Diabetes Care·Jonathan B BrownAndrew Perry
Jun 11, 2008·Current Opinion in Clinical Nutrition and Metabolic Care·Robert M Cohen, Eric P Smith
Sep 11, 2008·Diabetes Care·Michael BodmerChristoph R Meier
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
May 9, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Maureen F MoenJeffrey C Fink
Apr 9, 2010·Seminars in Dialysis·Csaba P KovesdyKamyar Kalantar-Zadeh
Oct 28, 2010·Diabetes, Obesity & Metabolism·K P VasishtG L Bakris
Nov 26, 2010·Archives of Internal Medicine·Ronan RousselUNKNOWN Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators
Mar 4, 2011·The New England Journal of Medicine·Hertzel C GersteinWilliam T Friedewald
Dec 14, 2011·Diabetes & Metabolism·F BonnetP Zaoui
Jan 4, 2012·Diabetes Care·UNKNOWN American Diabetes Association
Oct 6, 2012·Diabetes & Metabolism·G F A AssogbaA Fagot-Campagna
Citations
Sep 23, 2016·BMC Nephrology·Jean-Michel HalimiBéatrice Fiquet
May 31, 2017·Clinical and Experimental Pharmacology & Physiology·Estela Cuevas-RomeroMargarita Martínez-Gómez
Dec 14, 2018·Clinical Kidney Journal·Cédric PinierJean-Michel Halimi